Senseonics has been granted a patent for a sensor that can be implanted in living animals to measure analytes like glucose or oxygen. The sensor includes an analyte indicator with fluorescent molecules and metal chelating compounds to prevent degradation. GlobalData’s report on Senseonics gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Senseonics Holdings Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Senseonics, Medical data analysis was a key innovation area identified from patents. Senseonics's grant share as of April 2024 was 43%. Grant share is based on the ratio of number of grants to total number of patents.

Implantable sensor for measuring analytes in living animals

Source: United States Patent and Trademark Office (USPTO). Credit: Senseonics Holdings Inc

A recently granted patent (Publication Number: US11963761B2) discloses a sensor designed for measuring analytes within living animals. The sensor comprises a housing with an analyte indicator covering a portion of its outer surface, containing fluorescent indicator molecules with boronate groups. Additionally, the sensor includes compounds with metal chelating moieties on its outer surface, which can be entrapped, chemically attached, or co-polymerized with the analyte indicator. The sensor can be implanted within the animal and is constructed to interact with degradative species without compromising its performance, with the metal chelating moieties reducing the degradation rate of the analyte indicator.

Furthermore, the patent details a method for fabricating the sensor, involving soaking the sensor in a composition containing metal chelating moieties to enhance its functionality. The sensor housing encases photodetectors sensitive to the fluorescent light emitted by the indicator molecules, ensuring accurate measurement. The compounds with metal chelating moieties listed in the patent include a variety of substances such as EDTA, cyclohexyl EDTA, and NTP, among others. The sensor may also include a drug-eluting polymer matrix and additional materials with metal chelating moieties to further enhance its capabilities. Overall, the patent highlights a novel sensor design with metal chelating moieties that play a crucial role in maintaining the sensor's integrity and performance within living animals.

To know more about GlobalData’s detailed insights on Senseonics, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.